Mind the GAPP: Insulin Therapy Woes

Earlier this week, Novo Nordisk released results of a sweeping new survey about how patients – both type 1 and type 2 – struggle with insulin therapy, and what doctors accredit that to.Entitled the Global Attitudes of Patients and Physicians in In…

Earlier this week, Novo Nordisk released results of a sweeping new survey about how patients – both type 1 and type 2 – struggle with insulin therapy, and what doctors accredit that to.Entitled the Global Attitudes of Patients and Physicians in In…

SOURCE: Healthline RSS Feed – Read entire story here.